Coronavirus vaccine from Oxford and AstraZeneca shows early promise

By Cassidy Morrison

Published July 20, 2020 3:24pm ET

Add Washington Examiner on Google

Coronavirus vaccine from Oxford and AstraZeneca shows early promise — A lab technician working a bottle containing for COVID-19 vaccine testing at Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand, Monday, May 25, 2020. Thai health officials said that scientists in Thailand have had promising results in testing a COVID-19 vaccine candidate on mice, and have begun testing on monkeys. | (Sakchai Lalit/AP)

A coronavirus vaccine candidate developed by Oxford University in the United Kingdom with pharmaceutical giant AstraZeneca has shown potential in preliminary trials.

Early human trials found that the vaccine candidate appears to be safe and induced an immune response to infection in all 1,077 volunteers, according to findings published Monday in the medical journal the Lancet.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

COVID-19 Vaccines